Precision Medicine by Oxford Global’s Post

Dear #multiomics friends! Wanted to share with you some discussion points we had in the last COST Action AtheroNET meeting in Valencia! 📌Which clinical bio markers for #cardiovascular disease are validated and approved? 📌Could MultiOmics enable biomarker discovery? 📌Do we need big number of data in order to identify relative bio markers? 📌How can we integrate medical immagine procedure with molecular diagnostic tools based on Omics? Happy to hear your thoughts! 👏👏👏🔥 #crowdsource #crowdsourcing #biomarker #biomarkerdiscovery #clinicaldata Olink Proteomics #cardioresearch

🔬 Join Our Webinar: Scalable Plasma Proteomics with the Evosep One 🔬 📅 Date: Thursday, April 04, 2024 🕒 Time: 15:00 GMT The field of plasma proteomics is witnessing a revolutionary transformation, thanks to the adoption of high-throughput techniques. These advancements are not just pushing the boundaries of what's possible in protein analysis; they're reshaping our understanding of disease mechanisms, biomarker discovery, and therapeutic target identification. With the capability to analyze large patient cohorts and identify hundreds to thousands of proteins simultaneously, these techniques are uncovering previously unknown biomarkers and therapeutic targets. The implications for medical research and patient care are profound and far-reaching. 👩🔬 What to Expect: In this insightful webinar, we'll dive deep into the world of scalable plasma proteomics workflows, with a special focus on the Evosep One. Whether you're a seasoned researcher or new to the field, you'll discover how these technologies are setting new standards in proteomics research. Don't miss this opportunity to learn from leading experts in the field and enhance your research capabilities. 🔗 Reserve your spot now! https://lnkd.in/eaUYyqns #Proteomics #EvosepOne #PlasmaProteomics #Webinar #MedicalResearch #BiomarkerDiscovery #TherapeuticTargets #HighThroughputTechniques

Delve into the future of precision medicine with Bio-Techne! This multiomics platform is transforming our understanding of disease by merging genomic data with transcriptomics, epigenomics, and proteomics. Download to read Bio-Techne's case study demonstrating enhanced colorectal classification and biomarker discovery! Don’t miss out! >>> https://bit.ly/3HUxX0a

In case you missed the big news last week, we've entered into a license and distribution agreement with Thermo Fisher Scientific for spatial biology systems and reagents. The agreement between Akoya and Thermo Fisher allows Akoya to market a combination of its spatial biology products, such as PhenoCycler-Fusion and PhenoImager, with Thermo Fisher's ViewRNA in situ hybridization assays. This collaboration will provide researchers with a streamlined workflow for rapid and whole-slide imaging of RNA and protein biomarkers, enabling them to gain comprehensive insights from tissue samples. https://bit.ly/3TSMr8g GenomeWeb #ThermoFisher #SpatialBiology #SpatialMultiomics #SpatialOmics #RNA #WholeSlide

🎧 Join us for our upcoming webinar 🎧 Advanced proteomic biomarker discovery for understanding disease pathophysiology Hear from Eric Schordan, Chief Scientific Officer at Firalis Molecular Precision to learn how combining the Olink Proteomics Explore platform with positive displacement liquid handling technology provides deeper insights into the mechanisms underlying various drugs and diseases, by providing a comprehensive readout of protein expression levels in biological samples. Register for the webinar today: https://lnkd.in/gwzpcQKz #liquidhandling #proteomics #lifescience

Case Study: Quantitative Analysis of In Vivo Labeled Mitochondrial Protein Mitochondrial ribosomes are specialized in the synthesis of several important inner membrane proteins of the respiratory chain. Stable isotope labeling by amino acids in cell culture (SILAC) is a labeling method that has almost no toxic side effects. Creative proteomics can provide SILAC-based marker quantification technology to accelerate your research on protein quantification, interactions, post-translational modifications, and new biomarkers. The following is a case study of our quantitative proteomic analysis based on the SILAC technique, including a presentation of the experimental methods and results. Download for more information. https://lnkd.in/gy4iFjyT

A few hours left before the webinar, where you can learn how genomics combined with proteomics at population-scale is transforming our understanding of disease biology and accelerating more effective drug development. Dr. Ryan Dhindsa will share findings from an ambitious project to map the influence of rare gene variants on the levels of almost 3,000 proteins measured in plasma from over 50,000 participants in the UK Biobank Pharma Proteomics Project. He will show the vital role played by rare variants in the regulation of the human proteome and discuss the implications for biomedical research and future healthcare. Register here: https://bit.ly/3UFuJno #proteomics #biomarkers #precisionmedicine #drugdevelopment

Join us at the Olink Proteomics World Virtual Conference! This event features the latest advancements in proteomics and proteogenomics. Connect with peers, identify potential collaborations and learn about how advanced protein biomarkers’ discovery tools can easily be applied into your own research. The agenda includes 3 tracks covering: 🔹Multiomics and Proteogenomics Disease risk prediction with polygenic and proteins risk scoring in the ageing population. 🔹Drug Discovery Identification of protein biomarkers for new robust drug targets. Learn about available cohorts and sample collections. 🔹Biomarker Discovery / Clinical Translation Identify actionable protein biomarkers to reduce the gap between genotype and phenotype. Register now: https://hubs.ly/Q02NMcCD0 #DrugDiscovery #ProteinBiomarkers #Multiomics #Proteogenomics #PolygeneticRiskScore #Olink #PopulationStudies #Formulatrix

Ready to accelerate your proteomics research? 💥 🌟From Clustering to GO and KEGG enrichment : Dive into our cutting-edge biostatistics offer, designed to validate your hypotheses and deliver a set of data and figures ready for scientific publication or preclinical validation. Tebubio is your European partner in biomarker discovery, leveraging profiling arrays, multiplex arrays, and targeted ELISA with precision. 🎯 Whether it's tissue or in vitro models, we tailor our expertise to your unique conditions, honed over 20 years of experience. From sifting through 8000 targets to pinpointing that one 🔬game-changing biomarker, we guide you through intracellular or secretome variations. Excited to learn more? Reach out one of our CRS project manager ready to discuss with you ! 📩 https://lnkd.in/euDTtSWT [WeAreTebubio] #Biomarker #Proteomics #research #drugdiscovery #biostatistics

Explore the next frontier in #companiondiagnostics in this 3-part #eBook on protein-based #CDx. See how next-gen #proteomics methods for protein #biomarkerdiscovery are opening exciting new avenues in CDx development. 𝐘𝐨𝐮'𝐥𝐥 𝐥𝐞𝐚𝐫𝐧: ⚪️ The predictive value offered by dynamic protein biomarkers for CDx applications. ⚪️ How mass spectrometry-based proteomics is expanding the CDx landscape with deeper coverage of the plasma & tissue proteome. ⚪️ Approaches to rapidly translate protein #biomarkers for clinical impact. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐧𝐨𝐰! https://lnkd.in/gpPcr2vd